Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd.
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is...
advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 15, 2022 6:22am
TDR Tweet ..
This is potentially big news for $RVVTF. Pfizer just stopped their trial for standard risk patients for Paxlovid for COVID treatment. The data showed no improvement. Door wide open for Revive to
...more
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 14, 2022 5:08pm
Pfizer stops enrollment in Paxlovid trial in standard-risk..
#Bucillamine https://www.cnbc.com/2022/06/14/pfizer-stops-enrollment-in-covid-antiviral-trial-in-standard-risk-population-.html
Silvercorp to Acquire Adventus, Creating a Diversified Mining Company
posted May 02, 2024 9:00am by
Adventus Mining Corp.
-
|
Under the terms of the Arrangement Agreement, each holder of the common shares of Adventus will receive 0.1015 of one Silvercorp common share in exchange for each Adventus Share at the effective time of the Transaction. The Exchange Ratio implies consideration of C$0.50 per Adventus Share ...read more
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 13, 2022 8:48pm
FDA Wake UP IDITOS !! - TIME to EUA #Bucillamine
#Bucillamine L.A. County coronavirus cases, hospitalizations rising again, dashing hopes surge has crested https://www.latimes.com/california/story/2022-06-10/l-a-county-coronavirus-cases-covid
...more
(42)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Jun 11, 2022 8:45am
Just in case
If BUC fails we got this too! https://www.cnn.com/2022/06/11/health/psilocybin-brain-changes-life-itself-wellness-scn/index.html
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 10, 2022 8:30pm
The Virus Is Still Winning ! Bucillamine to the WORLD !!
#Bucillamine It's Time Folks !! https://www.project-syndicate.org/commentary/covid-19-vaccines-not-enough-need-new-antivirals-by-william-a-haseltine-2022-06?utm_source=facebook&utm_medium
...more
(42)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Comment by
ENEMENEMYNEMO
on Jun 08, 2022 6:09pm
RE:Level 2 this morning
Trying to force a sell-off to grab more... they kept pulling the ask when things got close... didn't work suckers.... obviously people are seeing good things to come. Raymond James hire
...more
(2)
•••
kiskadog
X
View Profile
View Bullboard History
Post by
kiskadog
on Jun 08, 2022 10:08am
Level 2 this morning
Orders Shares Bid Ask Shares Orders 6 57,000 0.445 0.45 500
...more
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 07, 2022 5:23pm
$RVV - Reddit post by BMT !
#Bucillamine https://www.reddit.com/r/RVVTF/comments/v6w8bh/updated_list_of_mechanisms/
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 07, 2022 6:13am
$RVV - The Dales Report !
#Bucillamine Submits Key Data Access Plan To The FDA https://thedalesreport.com/trends/revive-therapeutics-submits-key-data-access-plan-to-the-fda/?fbclid
...more
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 06, 2022 8:30pm
SADS - Sudden Adult Death Syndrome - Important Read Folks !!
https://www.mirror.co.uk/news/world-news/woman-31-who-went-gym-27098878
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 06, 2022 8:16pm
$RVV - Reddit post ..
#Bucillamine https://www.reddit.com/r/RVVTF/comments/v69vv9/thank_you_michael_frank_reviveteam_for_keeping_us/
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jun 06, 2022 2:23pm
$RVV Update !
https://ca.finance.yahoo.com/news/revive-therapeutics-provides-phase-3-175400508.html
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 06, 2022 1:55pm
New Press Release - Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
The Company submits Data Access Plan to the FDA to determine potential new clinical endpoints to support Emergency Use Authorization TORONTO, June 06, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life...
read article.
(835)
•••
CrazyProphet
X
View Profile
View Bullboard History
Post by
CrazyProphet
on Jun 06, 2022 1:19pm
Tightening the screws
for big bounce IMO !!! Anytime soon works !!!
(0)
•••
GenevaC
X
View Profile
View Bullboard History
Post by
GenevaC
on Jun 03, 2022 5:43am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up